Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Lidia Schapira"'
Autor:
Rachel Gaither, Rulla M. Tamimi, Philip D. Poorvu, Ann H. Partridge, Virginia F. Borges, Kathryn J. Ruddy, Lidia Schapira, Yue Zheng, Jeffrey Peppercorn, Shoshana M. Rosenberg, Steven E. Come
Publikováno v:
Cancer Research. 81:PD2-08
Background: Young age at diagnosis is an independent risk factor for recurrence and death from breast cancer (BC), with the greatest impact of young age demonstrated in hormone receptor positive (HR+) disease. Younger women are less likely to be adhe
Autor:
Rachel Gaither, Laura S. Dominici, Laura C. Collins, Linda M. Pak, Steven E. Come, Ellen Warner, Rulla M. Tamimi, Lidia Schapira, Hee Jeong Kim, Yue Zheng, Tari A. King, Kathryn J. Ruddy, Jeffrey Peppercorn, Shoshana M. Rosenberg, Virginia F. Borges, Ann H. Partridge, Philip D. Poorvu, Hilde Vardeh
Publikováno v:
Annals of Surgery. 276:173-179
OBJECTIVE We aimed to investigate eligibility for breast-conserving surgery (BCS) pre- and post-neoadjuvant systemic therapy (NST), and trends in the surgical treatment of young breast cancer patients. BACKGROUND Young women with breast cancer are mo
Autor:
Tal Sella, Kathryn J. Ruddy, Eric P. Winer, Yaileen D Guzman-Arocho, Rulla M. Tamimi, Debbie M Jakubowski, Lidia Schapira, Ellen Warner, Laura C. Collins, Philip D. Poorvu, Shari Gelber, Jeffrey Peppercorn, Shoshana M. Rosenberg, Ann H. Partridge, Steven E. Come, Christy A. Russell, Laura S. Dominici, Virginia F. Borges, Hee Jeong Kim, Craig Snow
Publikováno v:
Breast Cancer Research and Treatment. 186:157-165
The 21-gene Breast Recurrence Score test predicts benefit from adjuvant chemotherapy in estrogen receptor-positive, HER2-negative (ER+/HER2−) breast cancer (BC). We examined whether the 21-gene assay predicts response to neoadjuvant chemotherapy (N
Autor:
Judy Garber, Lidia Schapira, Craig Snow, Kathryn J. Ruddy, Elena F. Brachtel, Virginia F. Borges, Hilde Vardeh, Ellen Warner, Laura C. Collins, Ann H. Partridge, Steven E. Come, Jonathan D. Marotti, Philip D. Poorvu, Jeffrey Peppercorn, Shoshana M. Rosenberg, Yaileen D Guzman-Arocho, Gregory J. Kirkner, Rulla M. Tamimi
Publikováno v:
British Journal of Cancer, 126(2), 302-309. Nature Publishing Group
Br J Cancer
Br J Cancer
Background Breast cancer in young women is more likely to have higher risk features and be associated with germline BRCA1/BRCA2 mutations. We present the clinicopathologic features of breast cancers in a prospective cohort of young women, and associa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::336838ef24e883e5aea5e6f18b80b688
https://cris.maastrichtuniversity.nl/en/publications/5405adf5-0532-42c1-ae99-2e1727b4525a
https://cris.maastrichtuniversity.nl/en/publications/5405adf5-0532-42c1-ae99-2e1727b4525a
Autor:
Yaileen D Guzman-Arocho, Kathryn J. Ruddy, Lidia Schapira, Ann H. Partridge, Rulla M. Tamimi, Philip D. Poorvu, Ellen Warner, Laura C. Collins, Virginia F. Borges, Jeffrey Peppercorn, Shoshana M. Rosenberg, Elena F. Brachtel, Greg Kirkner, Craig Snow, Steven E. Come
Publikováno v:
Cancer Research. 80:P4-07
Background: Breast cancer arising in young women is more likely to have higher risk features than in older women and more likely to be associated with germline BRCA1 or BRCA2 mutations. We previously reported a higher distribution of luminal B-like t
Autor:
Shari Gelber, Rulla M. Tamimi, Kathryn J. Ruddy, Virginia F. Borges, Philip D. Poorvu, Lidia Schapira, Yue Zheng, Jeffrey Peppercorn, Shoshana M. Rosenberg, Ann H. Partridge, Steven E. Come
Publikováno v:
Cancer
Background Fear of cancer recurrence (FCR) is more intense in younger women. Because FCR is a powerful determinant of quality of life, identifying those at risk for persistently elevated FCR can inform timing of interventions. Methods A total of 965
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b42963207d636a40070c03f72959397
https://europepmc.org/articles/PMC9397577/
https://europepmc.org/articles/PMC9397577/
Autor:
Matteo Lambertini, Philip D. Poorvu, Shari Gelber, Lidia Schapira, Yue Zheng, Jeffrey Peppercorn, Shoshana M. Rosenberg, Rulla M. Tamimi, Kathryn J. Ruddy, Steven E. Come, Virginia F. Borges, Ann H. Partridge
BACKGROUND Many young women with newly diagnosed breast cancer are interested in future pregnancies. Prospective data regarding fertility interest and reproductive patterns after diagnosis are needed to counsel patients. METHODS The Young Women's Bre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22ed6e9e90dda7d829243c636b1bc9a3
http://hdl.handle.net/11567/1036249
http://hdl.handle.net/11567/1036249
Autor:
Beverly Moy, Barbara L. Smith, Steven J. Isakoff, Michelle C. Specht, Rachel B. Jimenez, Laura Spring, Leif W. Ellisen, Suzanne B. Coopey, Rachel A. Greenup, Andrzej Niemierko, Lidia Schapira, Alphonse G. Taghian, Kevin S. Hughes, Aditya Bardia, Stephanie Haddad
Publikováno v:
Journal of the National Comprehensive Cancer Network. 15:1216-1223
Purpose: Breast cancer in young women is associated with an aggressive tumor biology and higher risk of recurrence. Pathologic complete response (pCR) after neoadjuvant therapy has been shown to be a surrogate marker for disease-free survival (DFS) a
Autor:
Ann H. Partridge, Laura S. Dominici, Tari A. King, Kathryn J. Ruddy, Ellen Warner, Lidia Schapira, Hee Jeong Kim, Jeffrey Peppercorn, Jiani Hu, Virginia F. Borges, Shoshana M. Rosenberg, Julia Wong, Rulla M. Tamimi, Stephen Come
Publikováno v:
Cancer Research. 80:PD6-1
Background: Young women with breast cancer (BC) often receive aggressive local therapy and are more likely to undergo (bilateral) mastectomy and receive postmastectomy radiation (RT) than older women. Our previous work suggested better quality of lif
Autor:
Shari Gelber, Ann H. Partridge, Rulla M. Tamimi, Lidia Schapira, Kathryn J. Ruddy, Virginia F. Borges, Karen Sepucha, Evan Morgan, Steven E. Come, Shoshana M. Rosenberg, Nan Lin
Publikováno v:
Cancer Research. 75:P2-10
Background: There is an increasing recognition that many young women with breast cancer will have favorable outcomes without chemotherapy. We sought to characterize decision-making surrounding adjuvant chemotherapy treatment (CT) in this population f